Subsequently, the effect of exosome-derived ENO1 on the proliferation and metastasis of HCC cells was evaluated in vitro and in vivo, revealing that exosome-derived ENO1 promotes HCC progression by regulating the expression of integrin α6β4 and the activation of downstream signaling pathways. The gene discussed is ENO1; the disease is hepatocellular carcinoma.